Which drugs does patent 8,282,966 protect, and when does it expire?
|Title:||Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide|
|Abstract:||The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.|
|Inventor(s):||Baldassarre; James S. (Doylestown, PA), Rosskamp; Ralf (Chester, NJ)|
|Assignee:||INO Therapeutics LLC (Hampton, NJ)|
Patent Claim Types:|
see list of patent claims
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|GAS;INHALATION||020845-002||Dec 23, 1999||DISCN||Yes||No||8,282,966*PED||► Subscribe||Y|
|GAS;INHALATION||020845-003||Dec 23, 1999||RX||Yes||Yes||8,282,966*PED||► Subscribe||Y|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.